This battle is called oxidative stress
This is a hypothetical configuration in pre-publication research literature
At Geneva, weight loss is treated as a medical process , not a cosmetic one
This review discusses the origins of ROS, the impact of antioxidant systems on ROS dynamics, the main types and mechanisms of oxidative cell death, and the prospective use of small-molecular compounds or drugs to induce oxidative cell death as a tactic to counteract cancer
That doesn't necessarily mean the first medication "failed." People respond differently to GLP-1 drugs, and some tolerate or respond to one medication better than another
NCT04847557) seeks to evaluate the effect of tirzepatide (is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors) over 52 weeks in 700 patients with heart failure with preserved ejection fraction (HFpEF) and obesity